Image (3ef2b141 9ef9 4363 9c5b F70274e00d37 01)
Mesalamine Capsule, Extended Release
Product Images NDC 68382-452
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 68382-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (3ef2b141 9ef9 4363 9c5b F70274e00d37 02)
This is a description of Mesalamine extended-release capsules, USP containing 120 capsules with each capsule containing mesalamine, USP 0.375 g. The usual dosage is available in the package insert for full prescribing information. The package is child-resistant and should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). It is manufactured by Cadila Healthcare Ltd. in Ahmedabad, India and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ 08534. It is important to keep this and all drugs out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
